It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Karyopharm Therapeutics Inc. (KPTI) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.01, or -0.41%, to $2.44. The Karyopharm Therapeutics Inc. has recorded 15,647 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Karyopharm Therapeutics Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $2.45 and fluctuated between $2.4500 as its day high and $2.2800 as its day low. The current market capitalization of Karyopharm Therapeutics Inc. is $299.66M. A total of 2.26 million shares were traded on the day, compared to an average of 2.64M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, KPTI has seen 7 BUY and 8 SELL insider trades, representing the acquisition of 772,000 and the disposition of 78,517 shares. Over the last 12 months, there were 12 BUYs and 32 SELLs from insiders. Insiders purchased 879,576 shares during that period but sold 658,256.
In the most recent transaction, Paulson Richard A. sold 3,805 shares of KPTI for 3.35 per share on May 04. After the transaction, the President and CEO now owns 812,814 company shares. In a previous transaction on Apr 20, Rangwala Reshma sold 6,770 shares at 4.05 per share. KPTI shares that EVP & Chief Medical Officer owns now total 158,230.
Among the insiders who sold shares, Paulson Richard A. disposed of 3,497 shares on Apr 04 at a per-share price of $3.97. This resulted in the President and CEO holding 816,619 shares of KPTI after the transaction. In another insider transaction, Paulson Richard A. sold 3,506 shares at $3.16 per share on Mar 06. Company shares held by the President and CEO now total 820,116.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for KPTI in the last 3 months, the mean price target is $7.20 with high estimates of $10.00 and low estimates of $5.00. In terms of 52-week highs and lows, KPTI has a high of $6.84 and a low of $2.32.
As of this writing, KPTI has an earnings estimate of -$0.34 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.37. The company reported an EPS of -$0.43 in the last quarter, which was -22.90% lower than expectations of -$0.35.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. KPTI’s latest balance sheet shows that the firm has $228.62M in Cash & Short Term Investments as of fiscal 2021. There were $169.29M in debt and $73.72M in liabilities at the time. Its Book Value Per Share was -$0.40, while its Total Shareholder’s Equity was -$79.67M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KPTI is Buy with a score of 4.10.